Recent Finacing
Recent Raise
GlycoVaxyn is a Zurich-based biotech developing conjugate vaccines for bacterial infections and advancing vaccine candidates toward clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
